Back to top
more

Applied Therapeutics (APLT)

(Real Time Quote from BATS)

$0.46 USD

0.46
294,023

+0.02 (4.38%)

Updated Aug 4, 2025 03:08 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth C Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (143 out of 246)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Aeglea BioTherapeutics (AGLE) Catches Eye: Stock Jumps 5.1%

by Zacks Equity Research

Aeglea BioTherapeutics (AGLE) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Zacks Equity Research

Why Applied Therapeutics (APLT) Stock Might be a Great Pick

by Zacks Equity Research

Applied Therapeutics (APLT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Zacks Equity Research

Selecta Biosciences (SELB) in Focus: Stock Moves 7.4% Higher

by Zacks Equity Research

Selecta Biosciences (SELB) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Zacks Equity Research

Applied Therapeutics Inc. (APLT) Moves to Strong Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Applied Therapeutics Inc. (APLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Equity Research

Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (APLT) Outperforming Other Medical Stocks This Year?

Tirthankar Chakraborty headshot

New Strong Buy Stocks For June 17th

by Tirthankar Chakraborty

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Zacks Equity Research

The Zacks Analyst Blog Highlights: Onconova Therapeutics, Abeona Therapeutics, Proteostasis Therapeutics, Applied Therapeutics and Ennis

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Onconova Therapeutics, Abeona Therapeutics, Proteostasis Therapeutics, Applied Therapeutics and Ennis

Sweta Killa headshot

5 Top-Ranked Stocks Beating the Market at Midway Q1

by Sweta Killa

Better-than-expected earnings, positive development in the U.S.-China trade relationship, China stimulus measures, easing policies and slew of upbeat economic data buoyed the stocks.

Tirthankar Chakraborty headshot

US Dollar Flexes Muscles Against Other Currencies: 5 Winners

by Tirthankar Chakraborty

The US dollar drew support from a healthy domestic economy, and Fed's cautiously optimistic stance about holding interest rates despite the coronavirus outbreak.

Zacks Equity Research

Applied Therapeutics Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor Applied Therapeutics.

Zacks Equity Research

Applied Therapeutics Up on Positive Galactosemia Study Data

by Zacks Equity Research

Applied Therapeutics (APLT) soars on positive top-line results from the mid-stage study in adult Galactosemia patients on pipeline candidate, AT-007.

Zacks Equity Research

Company News for Jan 9, 2020

by Zacks Equity Research

Companies In The News Are: LTHM, NEWA, APLT, WBA

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for September 11th

by Zacks Equity Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 11th.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for September 9th

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 9th.

Zacks Equity Research

Applied Therapeutics, Inc. (APLT) Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Applied Therapeutics, Inc. (APLT).